Assessment of folate receptor-β expression in human neoplastic tissues

Jiayin Shen, Karson S. Putt, Daniel W. Visscher, Linda Murphy, Cynthia Cohen, Sunil Singhal, George Sandusky, Yang Feng, Dimiter S. Dimitrov, Philip S. Low

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Over-expression of folate receptor alpha on cancer cells has been frequently exploited for delivery of folate-targeted imaging and therapeutic agents to tumors. Because limited information exists on expression of the beta isoform of the folate receptor in human cancers (FR-β), we have evaluated the immunohistochemical staining pattern of FR-β in 992 tumor sections from 20 different human cancer types using a new anti-human FR-β monoclonal antibody. FR-β expression was shown to be more pronounced in cells within the stroma, primarily macrophages and macrophagelike cells than cancer cells in every cancer type studied. Moreover, FR-β expression in both cancer and stromal cells was found to be statistically more prominent in females than males. A significant positive correlation was also observed between FR-β expression on stromal cells and both the stage of the cancer and the presence of lymph node metastases. Based on these data we conclude FR-β may constitute a good target for specific delivery of therapeutic agents to activated macrophages and that accumulation of FR-β positive macrophages in the stroma could serve as a useful indicator of a tumor's metastatic potential.

Original languageEnglish
Pages (from-to)14700-14709
Number of pages10
JournalOncotarget
Volume6
Issue number16
StatePublished - 2015

Fingerprint

Folic Acid
Neoplasms
Macrophages
Stromal Cells
Folate Receptor 2
Folate Receptor 1
Protein Isoforms
Lymph Nodes
Monoclonal Antibodies
Staining and Labeling
Neoplasm Metastasis
Therapeutics

Keywords

  • Activated macrophage
  • Folate receptor
  • Folate receptor beta
  • Tumor associated macrophage

ASJC Scopus subject areas

  • Oncology

Cite this

Shen, J., Putt, K. S., Visscher, D. W., Murphy, L., Cohen, C., Singhal, S., ... Low, P. S. (2015). Assessment of folate receptor-β expression in human neoplastic tissues. Oncotarget, 6(16), 14700-14709.

Assessment of folate receptor-β expression in human neoplastic tissues. / Shen, Jiayin; Putt, Karson S.; Visscher, Daniel W.; Murphy, Linda; Cohen, Cynthia; Singhal, Sunil; Sandusky, George; Feng, Yang; Dimitrov, Dimiter S.; Low, Philip S.

In: Oncotarget, Vol. 6, No. 16, 2015, p. 14700-14709.

Research output: Contribution to journalArticle

Shen, J, Putt, KS, Visscher, DW, Murphy, L, Cohen, C, Singhal, S, Sandusky, G, Feng, Y, Dimitrov, DS & Low, PS 2015, 'Assessment of folate receptor-β expression in human neoplastic tissues', Oncotarget, vol. 6, no. 16, pp. 14700-14709.
Shen J, Putt KS, Visscher DW, Murphy L, Cohen C, Singhal S et al. Assessment of folate receptor-β expression in human neoplastic tissues. Oncotarget. 2015;6(16):14700-14709.
Shen, Jiayin ; Putt, Karson S. ; Visscher, Daniel W. ; Murphy, Linda ; Cohen, Cynthia ; Singhal, Sunil ; Sandusky, George ; Feng, Yang ; Dimitrov, Dimiter S. ; Low, Philip S. / Assessment of folate receptor-β expression in human neoplastic tissues. In: Oncotarget. 2015 ; Vol. 6, No. 16. pp. 14700-14709.
@article{ec4f7633285542578620dd1cfe2de0bb,
title = "Assessment of folate receptor-β expression in human neoplastic tissues",
abstract = "Over-expression of folate receptor alpha on cancer cells has been frequently exploited for delivery of folate-targeted imaging and therapeutic agents to tumors. Because limited information exists on expression of the beta isoform of the folate receptor in human cancers (FR-β), we have evaluated the immunohistochemical staining pattern of FR-β in 992 tumor sections from 20 different human cancer types using a new anti-human FR-β monoclonal antibody. FR-β expression was shown to be more pronounced in cells within the stroma, primarily macrophages and macrophagelike cells than cancer cells in every cancer type studied. Moreover, FR-β expression in both cancer and stromal cells was found to be statistically more prominent in females than males. A significant positive correlation was also observed between FR-β expression on stromal cells and both the stage of the cancer and the presence of lymph node metastases. Based on these data we conclude FR-β may constitute a good target for specific delivery of therapeutic agents to activated macrophages and that accumulation of FR-β positive macrophages in the stroma could serve as a useful indicator of a tumor's metastatic potential.",
keywords = "Activated macrophage, Folate receptor, Folate receptor beta, Tumor associated macrophage",
author = "Jiayin Shen and Putt, {Karson S.} and Visscher, {Daniel W.} and Linda Murphy and Cynthia Cohen and Sunil Singhal and George Sandusky and Yang Feng and Dimitrov, {Dimiter S.} and Low, {Philip S.}",
year = "2015",
language = "English",
volume = "6",
pages = "14700--14709",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "16",

}

TY - JOUR

T1 - Assessment of folate receptor-β expression in human neoplastic tissues

AU - Shen, Jiayin

AU - Putt, Karson S.

AU - Visscher, Daniel W.

AU - Murphy, Linda

AU - Cohen, Cynthia

AU - Singhal, Sunil

AU - Sandusky, George

AU - Feng, Yang

AU - Dimitrov, Dimiter S.

AU - Low, Philip S.

PY - 2015

Y1 - 2015

N2 - Over-expression of folate receptor alpha on cancer cells has been frequently exploited for delivery of folate-targeted imaging and therapeutic agents to tumors. Because limited information exists on expression of the beta isoform of the folate receptor in human cancers (FR-β), we have evaluated the immunohistochemical staining pattern of FR-β in 992 tumor sections from 20 different human cancer types using a new anti-human FR-β monoclonal antibody. FR-β expression was shown to be more pronounced in cells within the stroma, primarily macrophages and macrophagelike cells than cancer cells in every cancer type studied. Moreover, FR-β expression in both cancer and stromal cells was found to be statistically more prominent in females than males. A significant positive correlation was also observed between FR-β expression on stromal cells and both the stage of the cancer and the presence of lymph node metastases. Based on these data we conclude FR-β may constitute a good target for specific delivery of therapeutic agents to activated macrophages and that accumulation of FR-β positive macrophages in the stroma could serve as a useful indicator of a tumor's metastatic potential.

AB - Over-expression of folate receptor alpha on cancer cells has been frequently exploited for delivery of folate-targeted imaging and therapeutic agents to tumors. Because limited information exists on expression of the beta isoform of the folate receptor in human cancers (FR-β), we have evaluated the immunohistochemical staining pattern of FR-β in 992 tumor sections from 20 different human cancer types using a new anti-human FR-β monoclonal antibody. FR-β expression was shown to be more pronounced in cells within the stroma, primarily macrophages and macrophagelike cells than cancer cells in every cancer type studied. Moreover, FR-β expression in both cancer and stromal cells was found to be statistically more prominent in females than males. A significant positive correlation was also observed between FR-β expression on stromal cells and both the stage of the cancer and the presence of lymph node metastases. Based on these data we conclude FR-β may constitute a good target for specific delivery of therapeutic agents to activated macrophages and that accumulation of FR-β positive macrophages in the stroma could serve as a useful indicator of a tumor's metastatic potential.

KW - Activated macrophage

KW - Folate receptor

KW - Folate receptor beta

KW - Tumor associated macrophage

UR - http://www.scopus.com/inward/record.url?scp=84931043235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931043235&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 14700

EP - 14709

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 16

ER -